Houria Ichou
Publications by Year
Research Areas
HIV/AIDS Research and Interventions, HIV/AIDS drug development and treatment, HIV Research and Treatment, SARS-CoV-2 and COVID-19 Research, SARS-CoV-2 detection and testing
Most-Cited Works
- → Detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives(2020)76 cited
- → Evaluation of the RealStar® SARS-CoV-2 RT-PCR kit RUO performances and limit of detection(2020)50 cited
- → Raltegravir Concentrations in the Genital Tract of HIV-1-Infected Women Treated with a Raltegravir-Containing Regimen (DIVA 01 Study)(2011)33 cited
- → Evaluation of three extraction-free SARS-CoV-2 RT-PCR assays: A feasible alternative approach with low technical requirements(2021)31 cited
- → Usefulness of multiplex PCR methods and respiratory viruses’ distribution in children below 15 years old according to age, seasons and clinical units in France: A 3 years retrospective study(2017)31 cited
- → Performance evaluation of two SARS-CoV-2 IgG/IgM rapid tests (Covid-Presto and NG-Test) and one IgG automated immunoassay (Abbott)(2020)30 cited
- → Lopinavir/Ritonavir Monotherapy as a Nucleoside Analogue–Sparing Strategy to Prevent HIV-1 Mother-to-Child Transmission: The ANRS 135 PRIMEVA Phase 2/3 Randomized Trial(2013)25 cited
- → Pharmacokinetics, Safety and Efficacy of Ritonavir-Boosted Atazanavir (300/100 mg Once Daily) in HIV-1-Infected Pregnant Women(2014)13 cited
- → Etravirine Concentrations in the Cervicovaginal Compartment in HIV-1-Infected Women Receiving Etravirine-Containing Antiretroviral Therapy: DIVA 02 Study(2012)12 cited
- → Corrigendum to ‘detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives’(2021)9 cited